Drug Shortage Report for LEVITRA
| Report ID | 49555 |
| Drug Identification Number | 02250462 |
| Brand name | LEVITRA |
| Common or Proper name | Vardenafil tablets |
| Company Name | BAYER INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | VARDENAFIL |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 4's |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2018-06-30 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2020-11-16 |
| Shortage status | Resolved |
| Updated date | 2023-07-14 |
| Company comments | DIN discontinued as of November 16, 2020. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v21 | 2020-07-31 | French | Compare |
| v22 | 2023-07-14 | English | Compare |
| v23 | 2023-07-14 | French | Compare |